At the Annual World Muscle Society Congress, we're presenting six posters across our neuromuscular portfolio highlighting our work in Duchenne, Friedreich's ataxia and our proprietary POLARIS-101™ capsid, which is designed to enable safe and effective gene therapy delivery and has shown encouraging clinical signals in #Duchenne. We look forward to connecting with leading global experts to advance scientific progress in rare neuromuscular diseases. #WMS2026 #SolidInside

We look forward to attending the Annual Neuromuscular Study Group Scientific Meeting, where we'll share two posters highlighting our work in #Duchenne, including our POLARIS-101™ capsid and our Phase 1/2 INSPIRE DUCHENNE study. We value opportunities to engage with researchers, clinicians and advocates working to shape the future of patient care. #SolidInside #RareDisease

In honor of #WorldDuchenneAwarenessDay, we joined @JettFoundation at the Gals for Cal women's triathlon, coming together with the community to raise awareness, recognize progress and advance a future that is #StrongerThanDuchenne. Every day, we're proud to support greater access to care, continued research and inclusive experiences for individuals living with Duchenne. #WDAD2026

$SLDB: Today, our CEO Bo Cumbo will participate in a fireside chat at the @HCWCO 28th Annual Global Investment Conference. Join us live or watch the replay here: investors.solidbio.com/news-…

$SLDB: This week, our CEO Bo Cumbo and CMO Gabriel Brooks will participate in fireside chats at the @Official_Cantor Global Healthcare Conference and the @Citi Biopharma Back to School Summit. Tune in live or watch the replay here: investors.solidbio.com/news-…

Today on #WorldDuchenneAwarenessDay, we reflect on the profound impact that access to care, resources, scientific breakthroughs and opportunities can have for individuals and families affected by #Duchenne. We remain committed to advancing research and innovation, working alongside the Duchenne community in pursuit of meaningful progress. #WDAD2026 #RareDisease

Improving access for individuals living with Duchenne is about more than healthcare. It's about creating opportunities to fully participate in their communities and engage in activities they love. As we approach #WorldDuchenneAwarenessDay, we reflect on the importance of expanding access, and we stand with the Duchenne community in raising awareness, driving innovation and removing barriers. Read more from Annie Ganot, Solid Co-Founder, SVP Patient Advocacy and Duchenne mom. #WDAD2026 #RareDisease

$SLDB: We're looking forward to attending several investor conferences this month, where members of management will join fireside chats to discuss Solid's strategy and recent progress. Read more: investors.solidbio.com/news-…

Solid Biosciences today announced our financial results for the second quarter of 2026, along with business and pipeline updates. Read the full release: investors.solidbio.com/news-… #SolidBiosciences $SLDB

This weekend, #TeamSolid had a great time at the fourth annual rideATAXIA Hometown Boston bike ride, hosted by Friedreich's Ataxia Research Alliance (FARA). We're proud to join FARA and the local Boston community in advancing Friedreich's ataxia (FA) research. #FriedreichsAtaxia #FACommunity

With summer officially underway, we want to recognize the incredible impact our spring co-op cohort made over the past several months. Their hard work directly supported our mission to improve the lives of patients living with rare diseases. Day in and day out, they brought dedication, curiosity and passion to our teams. We are proud of their accomplishments during their time with us and wish them nothing but the best as they take the next steps in their careers! #TogetherWeAreSolid #SolidInside #SolidStartsHere

Solid Biosciences is looking forward to attending the 2026 Leerink Partners Therapeutics Forum in Boston on July 15, where members of the management will participate in 1x1 investor meetings. If you will be attending, we’d welcome the chance to connect. #SLDB #SolidBiosciences #Biotech #RareDisease #LeerinkPartners

We are proud to sponsor the 2026 What NOW? Virtual Conference hosted by @TeamJosephInfo, taking place July 15–16. Led by a committee of older adolescents and adults living with Duchenne, this event focuses on navigating the transition into adulthood, exploring key topics such as independence, higher education, career paths and relationships. You can learn more and register for the conference here: teamjoseph.org/what-now-conf… #WhatNOW2026 #Duchenne #RareDiseaseCommunity

Our Head of Corporate Strategy and Business Development, Shuli Roditi-Kulak, MD, MBA, recently joined leaders from across the industry at the @IAmBiotech (BIO) International Convention to discuss the future of biotech innovation and leadership. During the session, "At the Helm of Biopharma: Insights from Women Leading Science, Strategy and Scale," Shuli shared her perspective on how the biotech ecosystem must evolve to meet the next era of innovation. As scientific complexity increases, radical collaboration can unlock new models that empower companies to leverage shared knowledge and capabilities to accelerate progress for patients. Our #SolidInside efforts reflect this philosophy. We are working to expand access to next-generation enabling technologies that create new pathways for partnership across precision genetic medicine, allowing companies to focus more resources on innovation and less on rebuilding foundational infrastructure. #BIO2026

Thank you to @ParentProjectMD (PPMD) for a meaningful and engaging 2026 Annual Conference. Our team was grateful for the opportunity to connect with patients, families, advocates, clinicians and researchers from across the Duchenne community. During the conference, Kevin Flanigan, MD, of @nationwidekids and Principal Investigator in the Phase 1/2 INSPIRE DUCHENNE clinical trial, presented an overview of the SGT-003 development program during the Gene Therapy: Today & Tomorrow session. The presentation helped foster important discussions about ongoing research and the future of Duchenne treatment development. We're thankful to PPMD for bringing the community together and look forward to continuing these important conversations in support of individuals and families impacted by Duchenne. #PPMD2026 #Duchenne #GeneTherapy #RareDisease #DuchenneCommunity

As we head into the @ParentProjectMD (PPMD) Annual Conference, we are sharing the latest update with the Duchenne Community, including an overview of recent progress in our SGT-003 clinical development program. We are deeply grateful for our partnerships with patients, families and our clinical sites, and look forward to engaging at PPMD this weekend. Read more here: solidbio.com/letter-to-the-d…

We’re proud to be attending, sponsoring and exhibiting at @ParentProjectMD's 2026 Annual Conference, taking place June 25–27 in Orlando. This important meeting brings together the Duchenne community to connect, learn and discuss advancements toward new treatments. We look forward to engaging with patients, families, advocates, clinicians and partners throughout the conference. If you’re attending, stop by our exhibit table #4 to connect with the Solid Biosciences team. Learn more: parentprojectmd.org/events/p… #PPMD2026

Our Head of Corporate Strategy and Business Development, Shuli Kulak, M.D., will participate in @IamBiotech's International Convention breakout session, At the Helm of Biopharma: Insights from Women Leading Science, Strategy, and Scale. To learn more about the session, visit: convention.bio.org/2026-sess… #BIO2026

Looking forward to the conversations and connections at #BIO2026 next week. If you’re in the genetic medicine space and want to chat about platform partnerships or our pipeline, let's find some time to connect in San Diego. #GeneTherapy #BiotechInnovation Reach us at businessdevelopment@solidbio.com or through the BIO Partnering™ system, convention.bio.org/partner

We’re proud to share moments from the Team Solid at the recent Bio-Ball event! This event brought together the biotech community to support @SpOlympicsMA and the athletes who inspire us every day. It was an honor for our team to participate, compete and celebrate the power of inclusive sports. Huge thanks to the organizers and everyone who made this event unforgettable. #BIOBall #SpecialOlympics #SolidBiosciences #Community